"Atogepant: The chief oral drug developed specifically for prophylactic" by Abubakar Nazir, Mubarak Jolayemi Mustapha et al.
 

Atogepant: The chief oral drug developed specifically for prophylactic treatment of episodic migraine

Affiliations

St. Luke's Aurora Hospital

Document Type

Letter

Teammate Access


 

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Abstract Views: 3
see details

Share

COinS